Lead the Global Health Outcomes Team for our pipeline assets, providing scientific and strategic direction across the portfolio and leading a team of at least one direct report
Define the integrated evidence strategy, including patient-focused outcomes and clinical outcomes assessment strategy, economic models, and real-world evidence, aligned to regulatory, payer and other stakeholder needs
Represent value evidence in cross-functional integrated evidence teams and decision forums to influence development and launch decisions
Define and lead a portfolio-level Clinical Outcomes Assessment strategy, ensuring alignment with disease area needs, regulatory expectations, and payer evidence requirements
Drive the identification and integration of differentiated endpoints to strengthen value propositions across assets
Guide the development and use of fit-for-purpose instruments and endpoint frameworks, supporting consistency and scalability across the HIV portfolio
Partner with patient outcomes, clinical development, medical affairs and market access to translate strategy into study design, endpoints and evidence plans
Engage external stakeholders (payers, HTA bodies, guideline groups and academic partners) to ensure evidence meets decision-maker needs
Oversee quality, compliance, budget and delivery of health outcomes and real-world evidence studies across the product lifecycle.
Requirements
Advanced degree (Master’s or equivalent) in health outcomes, health economics, epidemiology, pharmacy, public health, or a related discipline
Significant pharmaceutical industry experience in health outcomes, real-world evidence, or value evidence roles
Line management experience
Demonstrated experience supporting reimbursement or HTA submissions across multiple markets
Proven ability leading cross-functional teams and working in complex matrix organisations
Strong scientific judgement in study design, patient-reported outcomes, and evidence synthesis
Excellent communication and influencing skills, including ability to translate data into strategic insights and business impact.